Skip to main content

Table 1 Patient characteristics

From: Differentiating prostate cancer from benign prostatic hyperplasia using whole-lesion histogram and texture analysis of diffusion- and T2-weighted imaging

Variable Value
PCa BPH
Patients (n, %) 90 (44.5) 112 (55.5)
Age (years) a 68.9±7.4 63.5±8.9
PSA level (ng/ml) b 14.88(9.05, 30.13) 9.81(7.26, 15.01)
Lesion volume (ml) b 2.50(1.10, 6.00) 1.05(0.70, 1.70)
PI-RADS score b 5 (4, 5) 2 (2, 2)
Gleason score
 3+3 (n, %) 27 (13.4) /
 3+4 (n, %) 17 (8.4) /
 4+3 (n, %) 14 (6.9) /
 ≥8 (n, %) 32 (15.8) /
  1. PCa prostate cancer, BPH benign prostatic hypertrophy, PSA prostate-specific antigen, PI-RADS prostate imaging reporting and data system
  2. a, and b, data are expressed as the mean ± standard deviation and the median (1st and 3rd quartile ranges), respectively